Detalhe da pesquisa
1.
Toll-like receptor 2-dependent protection against pneumococcal carriage by immunization with lipidated pneumococcal proteins.
Infect Immun
; 82(5): 2079-86, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24614661
2.
An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor Growth.
Cancer Discov
; 11(3): 696-713, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33504579
3.
Evolution of rational vaccine designs for genital herpes immunotherapy.
Curr Opin Virol
; 17: 80-86, 2016 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26896782
4.
Immune responses elicited by the GEN-003 candidate HSV-2 therapeutic vaccine in a randomized controlled dose-ranging phase 1/2a trial.
Vaccine
; 34(44): 5314-5320, 2016 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27642130
5.
Resolution of Chlamydia trachomatis Infection Is Associated with a Distinct T Cell Response Profile.
Clin Vaccine Immunol
; 22(11): 1206-18, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26446421
6.
Proteins as T cell antigens: methods for high-throughput identification.
Vaccine
; 31(37): 3805-10, 2013 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23806245
7.
High-throughput proteomic screening identifies Chlamydia trachomatis antigens that are capable of eliciting T cell and antibody responses that provide protection against vaginal challenge.
Vaccine
; 30(29): 4387-93, 2012 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22682294
8.
T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization.
Cell Host Microbe
; 9(2): 158-65, 2011 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21320698